Crystallization (Comment) | Organism |
---|---|
enzyme in complex with NAD+ and 19, X-ray diffraction structure determination and analysis at 2.7 A resolution | Toxoplasma gondii |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2E)-3-(6-aminopyridin-3-yl)-N-(4-methoxyphenyl)prop-2-enamide | - |
Toxoplasma gondii | |
(2E)-3-(6-aminopyridin-3-yl)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]prop-2-enamide | - |
Toxoplasma gondii | |
(2E)-3-[6-(acetylamino)pyridin-3-yl]-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]prop-2-enamide | - |
Toxoplasma gondii | |
(2E)-N-(2-aminobenzyl)-3-(6-aminopyridin-3-yl)prop-2-enamide | - |
Toxoplasma gondii | |
(2E,4E)-N-[3-chloro-4-(4-chloro-2-hydroxyphenoxy)phenyl]hexa-2,4-dienamide | - |
Toxoplasma gondii | |
(2E,4E)-N-[4-(2,4-dichlorophenoxy)-3-hydroxyphenyl]hexa-2,4-dienamide | - |
Toxoplasma gondii | |
1-(2-chlorobenzyl)-4-[(4-methoxybenzyl)oxy]pyridin-2(1H)-one | - |
Toxoplasma gondii | |
1-(3-chloro-4-nitrophenyl)-1,3-dihydro-2H-benzimidazol-2-one | - |
Toxoplasma gondii | |
1-(4-nitrobenzoyl)-1,3-dihydro-2H-benzimidazol-2-one | - |
Toxoplasma gondii | |
1-(4-nitrobenzyl)-1,3-dihydro-2H-benzimidazol-2-one | - |
Toxoplasma gondii | |
1-ethoxy-1-oxopropan-2-yl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate | - |
Toxoplasma gondii | |
1-[(4-nitrophenyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one | - |
Toxoplasma gondii | |
2-(2,4-dinitrophenoxy)-5-propylphenol | - |
Toxoplasma gondii | |
2-(2-chloro-4-nitrophenoxy)-5-propylphenol | - |
Toxoplasma gondii | |
2-(3-chlorophenoxy)-5-propylphenol | - |
Toxoplasma gondii | |
2-(3-nitrophenoxy)-5-propylphenol | - |
Toxoplasma gondii | |
2-(4-aminophenoxy)-5-propylphenol | - |
Toxoplasma gondii | |
2-(4-nitrophenoxy)-5-propylphenol | - |
Toxoplasma gondii | |
2-(biphenyl-4-yloxy)-5-chlorophenol | - |
Toxoplasma gondii | |
2-amino-N-(5-chloro-2-phenoxyphenyl)pyridine-3-carboxamide | - |
Toxoplasma gondii | |
2-[3-(2-hydroxyethyl)phenoxy]-5-propylphenol | - |
Toxoplasma gondii | |
3-chloro-4-(2,6-dihydroxy-4-propylphenoxy)benzoic acid | - |
Toxoplasma gondii | |
3-chloro-4-(2-hydroxy-4-propylphenoxy)benzonitrile | crystal and binding structure determination, overview | Toxoplasma gondii | |
3-chloro-4-(2-hydroxy-6-methoxy-4-propylphenoxy)benzonitrile | - |
Toxoplasma gondii | |
4-(2,6-dihydroxy-4-propylphenoxy)benzamide | - |
Toxoplasma gondii | |
4-(2,6-dihydroxy-4-propylphenoxy)benzonitrile | - |
Toxoplasma gondii | |
4-(4-hydroxyphenoxy)benzene-1,3-diol | - |
Toxoplasma gondii | |
4-(benzyloxy)-1-(2-chloro-4-nitrobenzyl)pyridin-2(1H)-one | - |
Toxoplasma gondii | |
4-(benzyloxy)-1-(2-chlorobenzyl)pyridin-2(1H)-one | - |
Toxoplasma gondii | |
4-phenoxybenzene-1,3-diol | - |
Toxoplasma gondii | |
4-[3-(9H-carbazol-9-yl)propoxy]-1-(2-chlorobenzyl)pyridin-2(1H)-one | - |
Toxoplasma gondii | |
4-{[4-(benzyloxy)-2-oxopyridin-1(2H)-yl]methyl}-3-chlorobenzamide | - |
Toxoplasma gondii | |
4-{[4-(benzyloxy)-2-oxopyridin-1(2H)-yl]methyl}-3-chlorobenzoic acid | - |
Toxoplasma gondii | |
4-{[4-(benzyloxy)-2-oxopyridin-1(2H)-yl]methyl}-3-chlorobenzonitrile | - |
Toxoplasma gondii | |
5-chloro-2-(2,4-dichlorophenoxy)phenol | - |
Toxoplasma gondii | |
5-chloro-2-(2,4-dichlorophenoxy)phenyl 2,2-dimethylpropanoate | - |
Toxoplasma gondii | |
5-chloro-2-(2-nitrophenoxy)phenol | - |
Toxoplasma gondii | |
5-chloro-2-(4-hydroxyphenoxy)phenol | - |
Toxoplasma gondii | |
5-chloro-2-(4-nitrophenoxy)phenol | - |
Toxoplasma gondii | |
5-chloro-2-(pyrazin-2-yloxy)phenol | - |
Toxoplasma gondii | |
5-chloro-2-(pyridin-3-yloxy)phenol | - |
Toxoplasma gondii | |
5-chloro-2-phenoxyaniline | - |
Toxoplasma gondii | |
5-chloro-2-phenoxyphenol | - |
Toxoplasma gondii | |
5-propyl-2-[4-(2H-tetrazol-5-yl)phenoxy]benzene-1,3-diol | - |
Toxoplasma gondii | |
additional information | drug design, synthesis, and evaluation of the compounds concerning antiparasite activity and toxicity to host cells, overview | Toxoplasma gondii | |
N-(3-aminophenyl)-2-(4-nitrophenoxy)acetamide | - |
Toxoplasma gondii | |
N-(4-methoxyphenyl)-2-(4-nitrophenoxy)acetamide | - |
Toxoplasma gondii | |
N-(5-chloro-2-phenoxyphenyl)-2,2-dimethylpropanamide | - |
Toxoplasma gondii | |
N-[2-(4-chloro-2-hydroxyphenoxy)phenyl]acetamide | - |
Toxoplasma gondii | |
N-[4-(4-chloro-2-hydroxyphenoxy)phenyl]acetamide | - |
Toxoplasma gondii | |
N-[5-(4-chloro-2-hydroxyphenoxy)pyridin-2-yl]acetamide | - |
Toxoplasma gondii | |
N1-phenylbenzene-1,2,4-triamine | - |
Toxoplasma gondii | |
triclosan | - |
Toxoplasma gondii | |
[3-(2-hydroxy-4-propylphenoxy)phenyl]boronic acid | - |
Toxoplasma gondii |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Toxoplasma gondii | Q6UCJ9 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
tachyzoite | - |
Toxoplasma gondii | - |
Synonyms | Comment | Organism |
---|---|---|
enoyl reductase | - |
Toxoplasma gondii |
ENR | - |
Toxoplasma gondii |
General Information | Comment | Organism |
---|---|---|
physiological function | enoyl reductase, ENR, a type II fatty acid synthase enzyme essential in parasites but not present in host animals | Toxoplasma gondii |